Collaborative Strategies to Ensure Optimal Application of the Latest Treatment Approaches in HCC

In this online educational program featuring downloadable slides an on-demand Webcast from a live symposium expert faculty explore strategies for providing optimal treatment for patients with advanced or metastatic HCC.

Share

Program Content

Activities

HCC Treatment
Navigating A New Therapeutic Era for HCC: Expert Review of New Agents and Guideline Recommendations
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 20, 2019

Expires: March 18, 2020

Activities

New Era for HCC Therapy
Navigating a New Therapeutic Era for HCC: Expert Review of New Agents and Guideline Recommendations
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2019

Expires: July 23, 2020

Faculty

cover img faculity

Thomas A. Abrams, MD

Institute Physician
Director, Liver Tumor Center
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

R. Kate Kelley, MD

Associate Professor
Division of Hematology and Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Stacey Stein, MD

Assistant Professor of Medicine
Yale University School of Medicine
Section of Medical Oncology
New Haven, Connecticut

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

This activity is supported by educational grants from:

Bayer Healthcare Pharma

Eisai

Partners

Clinical Care Options, LLC

ProCE Banner